Spruce Biosciences, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | $124.0K | $28.8M | $38.8M |
| FY2025 | $0 | $42.5M | $48.9M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | $124.0K | $28.8M | $38.8M |
| FY2025 | $0 | $42.5M | $48.9M |